Clinical Trial Update: A Trial of CM-AT in Children With Autism- Open Label Extension Study [Phase 3]

View source ↗

Summary

Open-label extension study reporting completion of a phase 3 trial evaluating CM-AT in children with autism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• CM-AT

Snippet

Sponsor: Curemark | Conditions: Autism | Phase 3 | Status: COMPLETED